The WHO Hub for Pandemic and Epidemic Intelligence is part of WHO’s Health Emergencies Programme and will be a new collaboration of countries and partners worldwide, driving innovations to increase availability and linkage of diverse data; develop tools and predictive models for risk analysis; and to monitor disease control measures, community acceptance and infodemics. Critically, the WHO Hub will support the work of public health experts and policy-makers in all countries with insights so they can take rapid decisions to prevent and respond to future public health emergencies.
Archiv: Coalition for Epidemic Preparedness Innovations (CEPI)
Corona-Politik: Simulation und Wirklichkeit
Die Tatsache, dass erste Fälle von Covid-19 nur zwei Monate nach dieser Simulation tatsächlich auftraten, und dass das Szenario der späteren Wirklichkeit so frappierend ähnlich war, gab natürlich Anlass zu Fragen und Spekulationen. Die Veranstalter verneinen jedoch, irgendeine frühere Kenntnis von dem realen Covid-19-Virus und der kommenden Seuche gehabt zu haben.
Das Event war aus jeder Perspektive perfekt ausgestaltet und organisiert. Die Gastgeber hatten weder Geld noch Mühen gescheut, um eine täuschend echte Simulation zu schaffen. Die Vorbereitung muss Monate in Anspruch genommen haben, das Event selbst wurde an einem Tag abgewickelt.
Denkt Boris Johnson mit?
Wir berichteten am 4. Dezember, dass der bereits im Frühjahr 2020 von der Oxford Universität entwickelte Impfstoff ChAdOx1 nCoV-19 (später AZD1222 oder Covishield) „jederzeit allen weiteren Varianten“ von SARS II angepasst werden kann. Wie der britische „Telegaph“ nun berichtet, geschieht dies jetzt.
Premierminister Boris Johnson, ansonsten umflutet von Myraden von Experten und sicherlich auch privat als Daddy gefordert, soll sich nun ausnahmsweise mit den Wissenschaftler.innen der Oxford Universität „intensiv“ unterhalten.
Es wurde auch Zeit.
AstraZeneca: ‘Manufacturing should take lion’s share of credit for vaccine success’
Back in March, Oxford University had “a limited manufacturing and supply capacity so they needed a partner,” Srinivasan said. “We decided to immediately offer our capacity in terms of the global reach. But that was only the beginning. Then we had to establish various alliances whether public partnerships that have been governments, or with for profit organizations or CMOs [some of which can be found here, here, and here], or not for profit organizations such as The Gates Alliance, GAVI, CEPI, and other organizations.”
Global partnership COVAX secures two billion COVID-19 vaccine doses
(19.12.2020)
UNITED NATIONS: Global vaccine partnership COVAX has lined up almost two billion doses of existing and candidate COVID-19 vaccines for use worldwide, including 200 million doses of the AstraZeneca/Oxford vaccine through an agreement between the Vaccine Alliance Gavi, the Serum Institute of India and the Bill and Melinda Gates Foundation.
Internationales WHO-Chef fordert gerechte Verteilung von Corona-Impfstoff
Er betonte, dass hierfür COVAX Facility, eine von der WHO geführte Initiative für den gemeinsamen Impfstoffkauf und die -verteilung, vier Milliarden Dollar benötige. Er bat die internationale Gemeinschaft um Unterstützung.
COVAX hatte am 18. Dezember mitgeteilt, fast zwei Milliarden Dosen von Corona-Impfstoffen sichergestellt zu haben.
USA lehnen weltweite Impfstoffinitiative ab
Covax wird federführend von den Impfallianzen Gavi und Cepi und von der WHO getragen.
Die USA waren im Juli aus der WHO ausgetreten.
Why the Bill Gates global health empire promises more empire and less public health
Behind a veil of corporate media PR, the Gates Foundation has served as a vehicle for Western capital while exploiting the Global South as a human laboratory. The coronavirus pandemic is likely to intensify this disturbing agenda.
GLOBAL VACCINATION SUMMIT: PANEL MEMBER BIOGRAPHIES ROUNDTABLE 1: „In Vaccines we trust: Stepping up action to increase vaccine confidence”
(12.09.2019)
JASON HIRSCH, Public Policy Manager,
Jason Hirsch joined Facebook’s Public Policy team in October 2018, where he focuses on development of policies to help guide Facebook’s approach to content distribution and moderation. Within that role, Mr. Hirsch heads up Facebook’s Health Integrity Policy efforts, including leading the development of Facebook’s multi-faceted approach to combatting misinformation about vaccinations.
ROADMAP FOR THE IMPLEMENTATION OF ACTIONS BY THE EUROPEAN COMMISSION BASED ON THE COMMISSION COMMUNICATION AND THE COUNCIL RECOMMENDATION ON STRENGTHENING COOPERATION AGAINST VACCINE PREVENTABLE DISEASE
(March 2019)
Examine the feasibility of developing a common vaccination card/passport for EU citizens (that takes into account potentially different national vaccination schedules and), that is compatible with electronic immunisation information systems and recognised for use across borders, without duplicating work at nati
Angebliche EU-Geheimpläne: Vom Immunitätsnachweis zur Zwangsimpfung?
Als „Beweis“ soll ein angeblich konspirativ verteiltes Papier herhalten, dass diese Absicht beweise. Das entsprechende Dokument „Roadmap on Vaccination“ gibt es tatsächlich – es ist jedoch alles andere als geheim: Jeder kann es vom EU-Server herunterladen.
Es handelt sich dabei auch nicht um eine Reaktion auf die aktuelle Corona-Pandemie, sondern um eine Initiative gegen vermeidbare Krankheiten, die bereits 2018 vom Rat der Europäischen Union ins Leben gerufen worden war.
WHO and UN launch drive to accelerate vaccine development
As the deaths caused by the coronavirus passed 190,000 at the global level and the number of cases crossed the 2.7 million threshold (Johns Hopkins University data updated Friday), a „historic collaboration“ was launched to accelerate the arrival of a vaccine.
Secretary-General’s remarks at the launch of the Statement of Commitment and Call for Support for the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 Tools [as delivered]
This launch brings together world leaders, the private sector, scientific and humanitarian actors and other partners to promote health, keep the world safe and advance the public good.
Human health is the quintessential global public good.
And today, we face a global public enemy like no other.
$8-billion effort aims to speed development of coronavirus vaccines and treatments
Friday’s launch event was co-hosted by French President Emmanuel Macron, European Commission President Ursula von der Leyen and philanthropists Bill and Melinda Gates.
Leaders from South Africa, Rwanda, Germany, Great Britain, Spain, Italy, Malaysia, Saudi Arabia, Finland and Costa Rica joined the call to pledge their commitment to work with and support the ACT Accelerator.
Representatives from the United States and China were noticeably absent.
Global collaboration to accelerate new COVID-19 health technologies
The launch of the new collaboration is being co-hosted by WHO Director-General Dr Tedros Adhanom Ghebreyesus, Emmanuel Macron, President of the French Republic, Ursula von der Leyen, President of the European Commission, and the Bill and Melinda Gates Foundation.
The virtual event will include senior United Nations, government and public health and industry leaders from around the world.
World leaders call for global collaboration in COVID-19 fight
World leaders have joined the World Health Organisation in calling for global collaboration to accelerate the development and equitable access to new COVID-19 tools, including vaccines.
Gates fordert Impfstoff-Finanzierung von G-20
Viele Länder hätten CEPI in den vergangenen zwei Wochen Unterstützung zukommen lassen, „doch benötigt die Koalition für ihre Arbeit mindestens zwei Milliarden Dollar“, so Gates. Die Gates-Stiftung hatte CEPI gemeinsam mit der Wellcome-Stiftung und mehreren Regierungen gegründet.
Event 201 Recommendations: Public-private cooperation for pandemic preparedness and response
(17.01.2020)
Public health authorities should work with private employers and trusted community leaders such as faith leaders, to promulgate factual information to employees and citizens. Trusted, influential private-sector employers should create the capacity to readily and reliably augment public messaging, manage rumors and misinformation, and amplify credible information to support emergency public communications. National public health agencies should work in close collaboration with WHO to create the capability to rapidly develop and release consistent health messages. For their part, media companies should commit to ensuring that authoritative messages are prioritized and that false messages are suppressed including though the use of technology.
Accomplishing the above goals will require collaboration among governments, international organizations and global business.
Pandemic simulation exercise spotlights massive preparedness gap
(November 06, 2019)
Event 201, hosted by the Johns Hopkins Center for Health Security, envisions a fast-spreading coronavirus with a devastating impact
The next epidemic is coming. Here’s how we can make sure we’re ready.
(27.04.2018)
Watching Hollywood thrillers, you’d think the world was pretty good at protecting the public from deadly microorganisms. We like to believe that somewhere out there, there is a team ready to spring into action – equipped with the latest and best technologies.
Government agents like Jack Bauer in 24. Harvard professors like Robert Langdon in Inferno. And WHO epidemiologists like Dr. Leonora Orantes in Contagion – who even risked getting kidnapped as she pursued “Patient Zero.”
In the real world, though, the health infrastructure we have for normal times breaks down very rapidly during major infectious disease outbreaks. This is especially true in poor countries. But even in the U.S., our response to a pandemic or widespread bioterror attack would be insufficient.
BILL GATES: A new kind of terrorism could wipe out 30 million people in less than a year — and we are not prepared
(18. Februar 2017)
When I decided 20 years ago to make global health the focus of my philanthropic work, I didn’t imagine that I’d be speaking at a conference on international security policy. But I’m speaking here at the Munich Security Conference because I believe our worlds are more tightly linked than most people realize.
Bill Gates Is Helping to Launch a Global Coalition to ‘Outsmart Epidemics’
(19. Januar 2017)
A new coalition to prevent epidemics was launched Wednesday at the World Economic Forum in Davos, with the aim of creating vaccines and other measures to preclude the spread of infectious disease.
The Coalition for Epidemic Preparedness Innovations (CEPI), backed by the governments of Germany, Japan and Norway with support from the Bill & Melinda Gates Foundation, will commit an initial $460 million to “outsmart epidemics,” the coalition said in a statement.
Event 201: Bill Gates & World Economic Forum Simulated Coronavirus Outbreak 6 Weeks Before First Case in Wuhan
(27.01.2020)
Event 201 is a pandemic tabletop exercise hosted by The Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation on October 18, 2019, in New York, NY. The exercise illustrated the pandemic preparedness efforts needed to diminish the large-scale economic and societal consequences of a severe pandemic. Drawing from actual events, Event 201 identifies important policy issues and preparedness challenges that could be solved with sufficient political will and attention. These issues were designed in a narrative to engage and educate the participants and the audience.
Coronavirus: Einen kleinen Staatsstreich spielen
Geht es nach dem Staat und seiner Presse, entscheidet demnächst die Regierung nach eigenem Ermessen wann Bevölkerung und Parlament sich versammeln, arbeiten oder aus dem Haus gehen dürfen.
So etwas nennt man dann einen Putsch.
Am morgigen Sonntag (22.03.) wird sich die Einheitsregierung („große Koalition“) der seit 15 Jahren amtierenden Kanzlerin Angela Merkel in einer Telefonkonferenz mit den Landesregierungen bezüglich bundesweiter „Ausgangssperren“ absprechen.
Es ist für alle Betroffenen, also Alle, wichtig dazu ein paar Dinge zu wissen.
(Yonhap Interview) COVID-19 vaccine, drugs on fast track for development: IVI chief
Phases 3 studies of Remdesivir made by U.S. pharmaceutical giant Gilead could take place in South Korea soon.
Battle of the Biotech Unicorns: CureVac vs. Moderna
(06.11.2017)
But despite being competitors, the companies’ CEOs seem to have quite a good relationship and consider each other collaborators rather than enemies. Every year, they organize an mRNA conference together that takes turns between Boston and Berlin to bring together all the stakeholders in the field. It was at this year’s edition, in Berlin, that I had the chance to bring them together for an interview regarding the future of mRNA therapies.
Coronavirus: Biotech company ships first batches of vaccine, to be tested on humans: report
The trials will be held at Kaiser Permanente Washington Health Research Institute in Seattle. Testing will involve 45 young, healthy volunteers and it uses Moderna’s mRNA-1273 vaccine.
„Unlike a normal vaccine, RNA vaccines work by introducing an mRNA sequence (the molecule which tells cells what to build) which is coded for a disease-specific antigen, once produced within the body, the antigen is recognized by the immune system, preparing it to fight the real thing,“ according to the University of Cambridge.
CureVac works on mRNA vaccine for coronavirus
Since 2006, the company has been manufacturing mRNA-based vaccines and therapeutics. It is currently looking to boost its manufacturing capacity to supply up to billions of doses during outbreaks.
CureVac chief technology officer Mariola Fotin-Mleczek said: “Nature has invented mechanisms to activate our immune system against infectious diseases. With our unique messenger RNA technology, we mimic nature and give our body the information on how to fight against the virus.
Coalition for Epidemic Preparedness Innovations: SARS-CoV-2
In January 2020, CEPI funded three teams working on a vaccine for SARS-CoV-2, being: Moderna, Inovio Pharmaceuticals, and the University of Queensland (UQ).[28][29] By February 2020, Inovio announced that it had produced a pre-clinical DNA-based vaccination to fight COVID-19 at its lab in San Diego.[30] Inovio collaborated with a Chinese firm to speed its acceptance by regulatory authorities in China for human trialing.[31] The strategy of the UQ team is to develop a molecular clamp vaccine that genetically modifies viral proteins to make them mimic the coronavirus and stimulate an immune reaction.[29][28]
In January 2020, CEPI announced a fourth SARS-CoV-2 project in a collaboration with their existing partner CureVac, to develop and manufacture a vaccine.
Moderna : Germany tries to halt U.S. interest in firm working on coronavirus vaccine
CureVac in 2015 and 2018 secured financial backing for development projects from its investor the Bill & Melinda Gates Foundation, working on shots to prevent malaria and influenza.
In the field of so-called mRNA therapeutics, CureVac competes with U.S. biotech firm Moderna and German rival BioNTech, which Pfizer has identified as a potential collaboration partner.
CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019
(31.01.2020)
The Federal Ministry of Education and Research (BMBF) is one of the founding members of the Coalition for Epidemic Preparedness Innovations and has committed a total of 90 million euro to its work. CEPI brings together a range of diverse stakeholders to develop much-needed vaccines for the prevention of future pandemics. Anja Karliczek, Federal Minister of Education and Research, said:
“The Coronavirus is currently the source of concern for many people. The development of a vaccine is an extremely important element in the effort to combat this viral infection. It is encouraging to see that this process now has the support of the international CEPI alliance, which is also making use of German research and development expertise. I hope that good results can soon be achieved for which so many people are waiting at this time.”
Corona-Medikament – Spahn: Impfstoff wird für ganze Welt entwickelt
„Wir sind in sehr guten Gesprächen übrigens schon seit zwei Wochen mit diesem Unternehmen.“ Die Meldung heute komme insofern „auch ein bischen zeitverzögert“.
Germany and US in tug of war as Donald Trump tries to buy rights to coronavirus vaccine
While more than two dozen pharmaceutical firms are in a race to develop the first effective vaccine against the coronavirus, CureVac may have an edge thanks to an experimental technology that allows it to deliver the prophylactic in extremely small doses.
It appears to have caught Mr Trump’s eye when he met the company’s chief executive during a crisis summit
Not true. The Welt story was wrong. But Business Insider, Reuters and others went with it anyway despite not having their own sources. Now everyone is back peddling.
Germany tries to stop Trump from luring away firm working on coronavirus vaccine
(March 15, 2020, 4:54 PM CET)
She declined to comment on any takeover possibilities but referred to Germany’s foreign trade law, under which Berlin can examine takeover bids from non-EU, so-called third countries „if national or European security interests are at stake“.
There was no comment immediately available from the U.S. embassy in Berlin when contacted by Reuters on Sunday over the report, and nobody was available to comment at CureVac. Welt am Sonntag said CureVac declined to comment.
Timetable For A Vaccine Against The New Coronavirus? Maybe This Fall: NPR
(12.02.2020)
CEPI is a global partnership of public, private and philanthropic organizations; it’s also supporting efforts at the biotech companies Moderna and CureVac.
(…)
Even in the rosiest of scenarios, Hatchett says, once the vaccine is in hand, it still needs to get to the people who need it, and that takes time — at least weeks to months, depending on the urgency.
The Event 201 scenario
(October 2019)
The disease starts in pig farms in Brazil, quietly and slowly at first, but then it starts to spread more rapidly in healthcare settings. When it starts to spread efficiently from person to person in the low-income, densely packed neighborhoods of some of the megacities in South America, the epidemic explodes. It is first exported by air travel to Portugal, the United States, and China and then to many other countries. Although at first some countries are able to control it, it continues to spread and be reintroduced, and eventually no country can maintain control.
There is no possibility of a vaccine being available in the first year.
Pandemic simulation exercise spotlights massive preparedness gap
(November 06, 2019)
Event 201, hosted by the Johns Hopkins Center for Health Security, envisions a fast-spreading coronavirus with a devastating impact
Germany tries to stop U.S. from luring away firm seeking coronavirus vaccine
German government sources told Reuters on Sunday that the U.S. administration was looking into how it could gain access to a potential vaccine being developed by a German firm, CureVac.
Earlier, the Welt am Sonntag German newspaper reported that U.S. President Donald Trump had offered funds to lure CureVac to the United States, and the German government was making counter-offers to tempt it to stay.
Germany’s CureVac says low-dose coronavirus vaccine could allow for mass production
(13.03.2020)
Privately held Curevac, which was granted up to $8.3 million by CEPI in January, is working to draw on its low-dose vaccine technology, which has showed promise in an early-stage rabies trial, for use against the coronavirus.
The Tuebingen, Germany, based company hopes to have an experimental vaccine ready by June or July to then seek the go-ahead from regulators for testing on humans.
CureVac CEO replaced in midst of biotech’s coronavirus push
(12.03.2020)
Last Monday, Menichella was among the top executives of nearly a dozen biotech and pharmaceutical companies briefing President Trump on their respective coronavirus drug development plans. Just over a week later, he was out as CEO, replaced by CureVac founder and former CEO Hoerr.
It’s a rapid transition in leadership at a time when the company is in the global spotlight for its efforts to quickly advance a coronavirus vaccine into human testing.
Kampf um Corona-Medikamente – USA wollen deutsche Impfstoffe aufkaufen
Die US-Regierung sei an einer exklusiven Nutzung des Impfstoffes für die USA interessiert. Das Unternehmen CureVac selbst war nicht für eine Stellungnahme erreichbar, ebenso wenig der Hauptinvestor der Firma. Dies ist dievini, die Biotechholding des SAP-Gründers Dietmar Hopp.
COVID-19 Coronavirus “Fake” Pandemic: Timeline and Analysis
(08.03.2020)
In the Event 201 Simulation of a Coronavirus Pandemic, a 15% collapse of financial markets had been “simulated”.
It was not “predicted” according to the organizers and sponsors of the event.
Private sector initiative. Participation of corporate execs, foundations, financial institutions, Banks, Big Pharma, CIA, CDC, No health officials on behalf of national governments or the WHO. The simulation exercise was held on the same day as the opening of the CISM World Militaty Sports Games in Wuhan.